Vision in Alzheimer's disease

a focus on the anterior afferent pathway

Victoria S. Pelak, William Hills

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Visual dysfunction has long been recognized as a manifestation of Alzheimer's disease (AD), particularly in the form of visuospatial impairment during all stages of disease. However, investigations have revealed findings within the anterior (i.e., pregeniculate) afferent visual pathways that rely on retinal imaging and electrophysiologic methodologies for detection. Here we focus on the anterior afferent visual pathways in AD and the measures used for assessment, including optical coherence tomography, electrophysiology, color vision testing and threshold visual field perimetry. A brief summary of higher order visual dysfunction is also included to allow the reader to keep in context the broader findings of afferent visual dysfunction in AD.

Original languageEnglish (US)
Pages (from-to)49-67
Number of pages19
JournalNeurodegenerative disease management
Volume8
Issue number1
DOIs
StatePublished - Feb 1 2018

Fingerprint

Afferent Pathways
Alzheimer Disease
Visual Pathways
Color Vision
Visual Field Tests
Electrophysiology
Optical Coherence Tomography
Visual Fields

Keywords

  • Alzheimer's disease
  • anterior visual function
  • electrophysiology
  • OCT
  • optical coherence tomography
  • visual field

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Vision in Alzheimer's disease : a focus on the anterior afferent pathway. / Pelak, Victoria S.; Hills, William.

In: Neurodegenerative disease management, Vol. 8, No. 1, 01.02.2018, p. 49-67.

Research output: Contribution to journalArticle

@article{76649e555da945cf90f4dc6f150de2fd,
title = "Vision in Alzheimer's disease: a focus on the anterior afferent pathway",
abstract = "Visual dysfunction has long been recognized as a manifestation of Alzheimer's disease (AD), particularly in the form of visuospatial impairment during all stages of disease. However, investigations have revealed findings within the anterior (i.e., pregeniculate) afferent visual pathways that rely on retinal imaging and electrophysiologic methodologies for detection. Here we focus on the anterior afferent visual pathways in AD and the measures used for assessment, including optical coherence tomography, electrophysiology, color vision testing and threshold visual field perimetry. A brief summary of higher order visual dysfunction is also included to allow the reader to keep in context the broader findings of afferent visual dysfunction in AD.",
keywords = "Alzheimer's disease, anterior visual function, electrophysiology, OCT, optical coherence tomography, visual field",
author = "Pelak, {Victoria S.} and William Hills",
year = "2018",
month = "2",
day = "1",
doi = "10.2217/nmt-2017-0030",
language = "English (US)",
volume = "8",
pages = "49--67",
journal = "Neurodegenerative disease management",
issn = "1758-2024",
publisher = "Future Medicine Ltd.",
number = "1",

}

TY - JOUR

T1 - Vision in Alzheimer's disease

T2 - a focus on the anterior afferent pathway

AU - Pelak, Victoria S.

AU - Hills, William

PY - 2018/2/1

Y1 - 2018/2/1

N2 - Visual dysfunction has long been recognized as a manifestation of Alzheimer's disease (AD), particularly in the form of visuospatial impairment during all stages of disease. However, investigations have revealed findings within the anterior (i.e., pregeniculate) afferent visual pathways that rely on retinal imaging and electrophysiologic methodologies for detection. Here we focus on the anterior afferent visual pathways in AD and the measures used for assessment, including optical coherence tomography, electrophysiology, color vision testing and threshold visual field perimetry. A brief summary of higher order visual dysfunction is also included to allow the reader to keep in context the broader findings of afferent visual dysfunction in AD.

AB - Visual dysfunction has long been recognized as a manifestation of Alzheimer's disease (AD), particularly in the form of visuospatial impairment during all stages of disease. However, investigations have revealed findings within the anterior (i.e., pregeniculate) afferent visual pathways that rely on retinal imaging and electrophysiologic methodologies for detection. Here we focus on the anterior afferent visual pathways in AD and the measures used for assessment, including optical coherence tomography, electrophysiology, color vision testing and threshold visual field perimetry. A brief summary of higher order visual dysfunction is also included to allow the reader to keep in context the broader findings of afferent visual dysfunction in AD.

KW - Alzheimer's disease

KW - anterior visual function

KW - electrophysiology

KW - OCT

KW - optical coherence tomography

KW - visual field

UR - http://www.scopus.com/inward/record.url?scp=85055228421&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055228421&partnerID=8YFLogxK

U2 - 10.2217/nmt-2017-0030

DO - 10.2217/nmt-2017-0030

M3 - Article

VL - 8

SP - 49

EP - 67

JO - Neurodegenerative disease management

JF - Neurodegenerative disease management

SN - 1758-2024

IS - 1

ER -